6 Pharma Stocks That Delivered Returns of Up to 225% in Just 6 Months; Do You Hold Any?

Synopsis: Pharma stocks surged as Bliss GVS Pharma, Kwality Pharma, Aptus Pharma, Venus Remedies, Rubicon Research, and Ind-Swift Laboratories delivered over 100% returns in six months, driven by strong growth and investor optimism.

The pharmaceutical sector has been one of the strongest performers in the stock market over the last six months, with several companies delivering multibagger returns. Investors have shown renewed interest in pharma stocks due to strong earnings, improving export demand, and a steady pipeline of new product launches. Companies receiving regulatory approvals and expanding into global markets have also supported the sector’s positive momentum.

Another major reason behind the rally is the improving outlook for Indian pharmaceutical exports, especially to regulated markets such as the United States and Europe. Government initiatives like the Production Linked Incentive (PLI) scheme, increasing investments in manufacturing, and a greater focus on reducing dependence on imported APIs have strengthened confidence in the industry. Many companies have also benefited from better operational efficiency and healthy demand for generic medicines.

As the healthcare sector continues to expand, investors are closely tracking pharma companies with strong product portfolios, export opportunities, and consistent financial performance. The following pharma stocks have delivered more than 100 percent returns in just six months, highlighting the sector’s strong growth potential and increasing investor confidence. Here are a few Pharma Stocks that delivered over 100% returns in just 6 months

Bliss GVS Pharma Limited

With a market capitalization of Rs. 5,574.02 crore, the shares of Bliss GVS Pharma Limited were currently trading at Rs. 526.90 per equity share, rising nearly 0.39 percent from its previous day’s close price of Rs. 524.85.

Bliss GVS Pharma Limited has given a massive multibagger return of 223.06 percent in the last 6 months, while delivering impressive returns of 384.66 percent over the last five years and 239.49 percent over the last one year.

Bliss GVS Pharma Limited is an Indian pharmaceutical company focused on developing, manufacturing, and marketing pharmaceutical formulations for domestic and international markets. Founded in 1984 and headquartered in Mumbai, the company has built a strong presence in export markets and is particularly recognized for its expertise in suppository and pessary dosage forms.

Kwality Pharmaceuticals Limited

With a market capitalization of Rs. 2,778.33 crore, the shares of Kwality Pharmaceuticals Limited were currently trading at Rs. 2,677.60 per equity share, down nearly 1 percent from its previous day’s close price of Rs. 2,704.70.

Kwality Pharmaceuticals Limited has given a massive multibagger return of 142.37 percent in the last 6 months, while delivering impressive returns of 1,348.91 percent over the last five years and 131.19 percent over the last one year.

Kwality Pharmaceuticals Limited is an Indian pharmaceutical manufacturing company headquartered in Amritsar, Punjab. Founded in 1983, it develops and manufactures finished pharmaceutical formulations for domestic and international markets and has built a reputation as an export-oriented producer with a broad range of dosage forms and regulatory certifications.

Aptus Pharma Limited

With a market capitalization of Rs. 401.31 crore, the shares of Aptus Pharma Limited were currently trading at Rs. 234.00 per equity share, rising nearly 1.74 percent from its previous day’s close price of Rs. 230.00.

Aptus Pharma Limited has given a massive multibagger return of 225.63 percent in the last 6 months, while delivering impressive returns of 589.45 percent over the last one year.

Aptus Pharma Limited is an Indian pharmaceutical company focused on the marketing and distribution of finished pharmaceutical formulations. Founded in 2010, it has expanded from a regional business into a publicly listed company on the BSE SME platform, with an emphasis on branded formulations across multiple therapeutic areas.

Venus Remedies Limited

With a market capitalization of Rs. 2,340.56 crore, the shares of Venus Remedies Limited were currently trading at Rs. 1,751 per equity share, down nearly 1.34 percent from its previous day’s close price of Rs. 1,774.80.

Venus Remedies Limited has given a massive multibagger return of 123.84 percent in the last 6 months, while delivering impressive returns of 330.43 percent over the last five years and 280.73 percent over the last one year.

Venus Remedies Limited is an Indian pharmaceutical company focused on the research, development, and manufacture of pharmaceutical formulations, with particular strength in injectable medicines. Founded in 1989, the company has expanded from its domestic base into international markets and is recognized for its emphasis on critical-care therapies, antimicrobial resistance research, and global regulatory compliance.

Rubicon Research Limited

With a market capitalization of Rs. 2,340.56 crore, the shares of Rubicon Research Limited were currently trading at Rs. 1,374.70 per equity share, rising nearly 0.54 percent from its previous day’s close price of Rs. 1,367.30.

Rubicon Research Limited has given a massive multibagger return of 107.64 percent in the last 6 months, while delivering impressive returns of 119.11 percent over the last one year.

Rubicon Research Limited is an Indian pharmaceutical company focused on the research, development, manufacturing, and commercialization of differentiated pharmaceutical formulations. Founded in 1999, it has grown from a formulation development company into a global business with a strong presence in the U.S. generic and specialty pharmaceutical markets, supported by research, manufacturing, and regulatory operations across multiple countries.

Ind-Swift Laboratories Limited

With a market capitalization of Rs. 1,800 crore, the shares of Ind-Swift Laboratories Limited were currently trading at Rs. 203 per equity share, rising nearly 1.12 percent from its previous day’s close price of Rs. 200.75.

Ind-Swift Laboratories Limited has given a massive multibagger return of 121.86 percent in the last 6 months, while delivering impressive returns of 101.70 percent over the last five years and 81.38 percent over the last one year.

Ind-Swift Laboratories Limited is an Indian pharmaceutical company headquartered in Chandigarh that develops, manufactures, and markets pharmaceutical products. The company is part of the Ind-Swift Group and has built an international presence through branded formulations, generic medicines, exports, research and development, and pharmaceutical manufacturing for multiple global markets.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post 6 Pharma Stocks That Delivered Returns of Up to 225% in Just 6 Months; Do You Hold Any? appeared first on Trade Brains.